Shanghai Zymetas Medtech Co., Ltd.
PrivateLast Round
D+
May 26, 2023
Est. Valuation
$125.94M
Total Funding Raised
$94.22M
Company Overview
Shanghai Zymetas Medtech Co., Ltd. is a biotechnology company that designs, develops, and manufactures in vitro diagnostic (IVD) solutions, including molecular detection assays and lyophilized reagent technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Zymetas Medtech Co., Ltd. Comparables
Compare Shanghai Zymetas Medtech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biofortuna | 80% | |
| Sansure Biotech Inc. | 66% | |
| Fapon Biotech | 64% |
Shanghai Zymetas Medtech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| D+ | May 26, 2023 | ||||
| Series D | May 6, 2021 | ||||
| Strategic | Oct 20, 2020 | ||||
| Series C | Nov 4, 2019 | ||||
| Series B Extension | Mar 29, 2017 | ||||
Series B | Sep 8, 2016 |
Shanghai Zymetas Medtech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza Holdings | Series D |
| Guoke Jiahe Capital | Series B |
| Shenzhen New Industry Venture Capital | Series B |
| 健壹资本 | Series D |
| 中金前海（深圳）私募股权基金管理有限公司 | Strategic |
| Shengshan Asset Management | Strategic |
| CICC Capital | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2023
Raised D+ round with Shanghai Fengxian Biomedical Science and Technology Park Development Co., Ltd. as investor.
- May 6, 2021
$39M round with participation from Oriza Holdings and Yunfeng Capital.
Shanghai Zymetas Medtech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Zymetas Medtech Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Zymetas Medtech Co., Ltd. a public or private company?
Shanghai Zymetas Medtech Co., Ltd. is a private company.
What is the current stock price of Shanghai Zymetas Medtech Co., Ltd.?
Shanghai Zymetas Medtech Co., Ltd. is a private company with no public stock price. Caplight tracks Shanghai Zymetas Medtech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Shanghai Zymetas Medtech Co., Ltd. worth (valuation)?
Shanghai Zymetas Medtech Co., Ltd.'s valuation is estimated at $125.9M based on funding round data.
Can I buy Shanghai Zymetas Medtech Co., Ltd. stock?
Shanghai Zymetas Medtech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Zymetas Medtech Co., Ltd.'s last funding round?
Shanghai Zymetas Medtech Co., Ltd.'s most recent funding round was D+ on September 8, 2016.
Who are the main investors in Shanghai Zymetas Medtech Co., Ltd.?
Key investors in Shanghai Zymetas Medtech Co., Ltd. include Shenzhen New Industry Venture Capital.
Will Shanghai Zymetas Medtech Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Zymetas Medtech Co., Ltd..
How can I track Shanghai Zymetas Medtech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Zymetas Medtech Co., Ltd.'s secondary market activity and sign up for updates.